Search and Neutralize Inhibitory Factors in Damaged Spinal Cord to Improve Transmission and Function – Dr. Victor Arvanian

Dr. Arvanian reports on the discoveries in his lab that he believes will improve transmission of signals in the damaged spinal cord. After identifying NG-2 as the specific CSPG blocking conduction in chronic SCI, he and his collaborators have developed an NG-2 antibody and are now working on delivery methods.

Without your valuable support of Unite 2 Fight Paralysis volunteers and your generous donations directed to the Working 2 Walk Video Library, the annual symposium video presentations could not be made possible for the paralysis community. (Thank you for your generous support in supplying this educational material for research and advocacy to cure paralysis).

This entry was posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research and tagged . Bookmark the permalink.